GCG100649, A Novel Cyclooxygenase‐2 Inhibitor, Exhibits a Drug Disposition Profile in Healthy Volunteers Compatible With High Affinity to Carbonic Anhydrase‐I/II: Preliminary Dose–Exposure Relationships to Define Clinical Development Strategies

Publisher： John Wiley & Sons Inc

E-ISSN： 2160-7648|2|4|379-386

ISSN： 2160-763X

Source： Clinical Pharmacology In Drug Development, Vol.2, Iss.4, 2013-10, pp. : 379-386

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dual Carbonic Anhydrase - Cyclooxygenase-2 Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 9, 2007-05 ,pp. : 885-891

Bentham Science Publishers

Access to resources Recommend Favorite

Carbonic anhydrase activators - Part 24. High affinity isozymes I, II and IV activators, derivatives of 4-(4-chlorophenylsulfonylureido-amino acyl)ethyl-1H-imidazole

By Scozzafava A.   Supuran C.T.  

European Journal of Pharmaceutical Sciences, Vol. 10, Iss. 1, 2000-03 ,pp. : 29-41

Elsevier

Access to resources Recommend Favorite

Multiple-Dose Pharmacokinetics and Safety of Bevirimat, a Novel Inhibitor of HIV Maturation, in Healthy Volunteers

By Martin David E.  

Clinical Pharmacokinetics, Vol. 46, Iss. 7, 2007-01 ,pp. : 589-598

Adis International

Access to resources Recommend Favorite

Drug Design Studies of the Novel Antitumor Targets Carbonic Anhydrase IX and XII

By  

Current Medicinal Chemistry, Vol. 17, Iss. 15, 2010-05 ,pp. : 1516-1526

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and Biological Potential Assessment of 2-Substituted Quinazolin-4(3H)-ones as Inhibitors of Phosphodiesterase-I and Carbonic Anhydrase-II

By  

Medicinal Chemistry, Vol. 11, Iss. 4, 2015-06 ,pp. : 336-341

Bentham Science Publishers

Access to resources Recommend Favorite